Last reviewed · How we verify

SafeTynadol® — Competitive Intelligence Brief

SafeTynadol® (SafeTynadol®) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic/antipyretic (acetaminophen derivative). Area: Pain Management / Fever.

marketed Analgesic/antipyretic (acetaminophen derivative) Presumed COX inhibitor and TRPV1 modulator (acetaminophen mechanism) Pain Management / Fever Small molecule Live · refreshed every 30 min

Target snapshot

SafeTynadol® (SafeTynadol®) — Sinew Pharma Inc.. SafeTynadol® is a modified formulation of acetaminophen designed to reduce hepatotoxicity risk through enhanced safety mechanisms.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SafeTynadol® TARGET SafeTynadol® Sinew Pharma Inc. marketed Analgesic/antipyretic (acetaminophen derivative) Presumed COX inhibitor and TRPV1 modulator (acetaminophen mechanism)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic/antipyretic (acetaminophen derivative) class)

  1. Sinew Pharma Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SafeTynadol® — Competitive Intelligence Brief. https://druglandscape.com/ci/safetynadol. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: